Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucía Romero-Pinel

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cognitive Neuropsychology|February 7, 2014
Losing control of your languages: a case studyMarco Calabria, Paula Marne, Lucía Romero-Pinel, et al.
International Archives of Allergy and Immunology|January 31, 2015
IgE-mediated allergic reactions after the first administration of glatiramer acetate in patients with multiple sclerosisMercè Corominas, Idoia Postigo, Victoria Cardona, et al.
Journal of Neurology|February 14, 2016
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
Plos One|November 15, 2014
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
European Neurology|March 21, 2015
Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosisÁlvaro Cobo-Calvo, Laura Bau, Elisabet Matas, et al.
Plos One|April 29, 2022
Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicatorLucía Romero-Pinel, Laura Bau, Elisabet Matas, et al.
BMC Neurology|October 5, 2013
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large seriesAlvaro Cobo Calvo, M Alba Mañé Martínez, Agustí Alentorn-Palau, et al.
Journal of Neuroimmunology|February 10, 2016
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
Journal of the Neurological Sciences|September 3, 2010
Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosisLucía Romero-Pinel, Josep María Pujal, Sergio Martínez-Yélamos, et al.
Journal of Neurology|March 13, 2023
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experimentAlbert Muñoz-Vendrell, Pablo Arroyo-Pereiro, Isabel León, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cognitive Neuropsychology|February 7, 2014
Losing control of your languages: a case studyMarco Calabria, Paula Marne, Lucía Romero-Pinel, et al.
International Archives of Allergy and Immunology|January 31, 2015
IgE-mediated allergic reactions after the first administration of glatiramer acetate in patients with multiple sclerosisMercè Corominas, Idoia Postigo, Victoria Cardona, et al.
Journal of Neurology|February 14, 2016
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
Plos One|November 15, 2014
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
European Neurology|March 21, 2015
Effectiveness of natalizumab in patients with highly active relapsing remitting multiple sclerosisÁlvaro Cobo-Calvo, Laura Bau, Elisabet Matas, et al.
Plos One|April 29, 2022
Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicatorLucía Romero-Pinel, Laura Bau, Elisabet Matas, et al.
BMC Neurology|October 5, 2013
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large seriesAlvaro Cobo Calvo, M Alba Mañé Martínez, Agustí Alentorn-Palau, et al.
Journal of Neuroimmunology|February 10, 2016
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patientsElisabet Matas, Laura Bau, María Martínez-Iniesta, et al.
Journal of the Neurological Sciences|September 3, 2010
Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosisLucía Romero-Pinel, Josep María Pujal, Sergio Martínez-Yélamos, et al.
Journal of Neurology|March 13, 2023
Natalizumab continuation versus switching to ocrelizumab after PML risk stratification in RRMS patients: a natural experimentAlbert Muñoz-Vendrell, Pablo Arroyo-Pereiro, Isabel León, et al.
Pageof 4